EMA says regulators pledge API inspection sharing but report modest progress

The European Medicines Agency reports that regulators worldwide are strongly committed to sharing plans for good manufacturing practice inspections of active pharmaceutical ingredient suppliers.

Despite this commitment, the sharing of actual inspection reports has only shown moderate progress in recent years.

Joint inspections remain difficult, with the number of such inspections falling by 50% compared to the previous reporting period, underscoring ongoing challenges.